Legal & General Group
BNGO icon

Legal & General Group’s Bionano Genomics BNGO Stock Holding History

Legal & General Group’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-213
Closed -$142K – 3426
2023
Q1 		$142K Buy
213
+11
+5% +$9.77K ﹤0.01% 2699
2022
Q4 		$177K Buy
202
+5
+3% +$6.29K ﹤0.01% 2659
2022
Q3 		$216K Sell
197
-149
-43% -$197K ﹤0.01% 2593
2022
Q2 		$287K Buy
346
+105
+44% +$108K ﹤0.01% 2513
2022
Q1 		$374K Buy
241
+7
+3% +$9.45K ﹤0.01% 2474
2021
Q4 		$420K Buy
234
+2
+0.9% +$5.35K ﹤0.01% 2467
2021
Q3 		$766K Buy
232
+125
+117% +$437K ﹤0.01% 2311
2021
Q2 		$470K Buy
+107
New +$422K ﹤0.01% 2346

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Legal & General Group's BNGO Position: Q2 2023 in Review

Legal & General Group sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 213 shares — an estimated $142K sold.

Legal & General Group first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $766K in Q3 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Legal & General Group reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Legal & General Group sold 213 Bionano Genomics shares in Q2 2023, an estimated $142K.
  • Legal & General Group first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
  • Legal & General Group's Bionano Genomics position peaked at $766K in Q3 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Legal & General Group's 13F filing for Q2 2023, filed 14 Aug 2023.